Oak Therapeutics Enters Battle Against Malaria

By: Oak Therapeutics
Spread the Word
Listed Under

* Drug Delivery
* Pharmaceutical
* Technology
* Oral Thin Film

* Biotech
* Health

* Oxnard - California - US

OXNARD, Calif. - June 24, 2015 - PRLog -- by Gerhard Apfelthaler

June 23rd , 2015

Oxnard, CA – Oxnard-based pharmaceutical start-up Oak Therapeutics successfully concluded the pre-clinical phase of its anti-malarial medication Artelutrine™. Artelutrine™ is a reformulation of a highly effective, WHO-recommended combination therapy of the active ingredients Artemether and Lumefantrine using Oak Therapeutics novel delivery system, oral dissolvable strips (ODS).

Artelutrine™ ODS will be used in the treatment for children with malaria. Malaria is an infective disease that kills close to 700,000 people annually, most of them children under five years. Another 165 million annually contract malaria, which then constitutes a major burden on education systems due to student absences, causes employee absences, and ultimately impacts the entire economies in Africa, Asia and even parts of Central and South America.

In the pre-clinical trial, Oak Therapeutics proved that its ODS delivery system is as effectively delivering the drugs as the most well-known pediatric anti-malarial currently on the market. Oak Therapeutics is also developing other medications using their ODS delivery system including antibiotics for use in pediatric patients with compromised immune systems, anti-retroviral drugs for pediatric HIV patients, and pediatric oral rehydration supplements that are used in the treatment of diarrhea, one of the planet’s deadliest diseases.

About Oak Therapeutics:

Oak Therapeutics  is a subsidiary of Cure Pharmaceutical in Oxnard CA. The mission of Oak Therapeutics focuses on big goals - global health, personal dignity and business sustainability. Oak Therapeutics aims to change the way in which quality medicines are brought to people in need while being highly profitable. Oak Therapeutics reformulates existing pharmaceuticals and nutraceuticals using a  proprietary drug delivery system, oral dissolvable strips, and distribute them where they're needed most - regions where people die from diseases that have simple cures such as diarrhea and malaria.

Contact and Further Information:

Ed Maliski, Ph.D.

Oak Therapeutics

1612 Fiske Pl

Oxnard, CA 93033

Email: maliski@oaktherapeutics.com

Ed Maliski, Ph.D.
Email:***@oaktherapeutics.com Email Verified
Tags:Drug Delivery, Pharmaceutical, Technology, Oral Thin Film
Industry:Biotech, Health
Location:Oxnard - California - United States
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Cure Pharmaceutical News
Most Viewed
Daily News

Like PRLog?
Click to Share